ABSTRACT

Reproductive medicine has been very successful at developing new therapies in recent years and people having difficulties conceiving have more options available to them than ever before. These developments have led to a new institutional landscape emerging and this innovative volume explores how health and social structures are being developed and reconfigured to take into account the increased use of assisted reproductive technologies, such as IVF treatments.

Using Sweden as a central case study, it explores how the process of institutionalizing new assisted reproductive technologies includes regulatory agencies, ethical committees, political bodies and discourses, scientific communities, patient and activists groups, and entrepreneurial activities in the existing clinics and new entrants to the industry. It draws on new theoretical developments in institutional theory and outlines how health innovations are always embedded in social relations including ethical, political, and financial concerns.

This book will be of interest to advanced students and academics in health management, science and technology studies, the sociology of health and illness and organisational theory.

chapter 1|24 pages

Introduction

The science of life and the market for babies

part I|54 pages

Theoretical perspectives

part II|86 pages

Empirical studies

chapter 4|10 pages

The methodology of the study

chapter 5|29 pages

Creating institutions

Advocating and promoting new ART

chapter 6|20 pages

Maintaining institutions

Pricing therapies and developing markets in the ART industry

chapter 7|25 pages

Disrupting institutions

Expanding the legal and regulatory framework

part III|13 pages

Institutionalizing ART

chapter 8|13 pages

The making of reproductive futures